Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NT-501 Implant in CNGB3 Achromatopsia
NCT01648452Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Jul 2012
- Primary completion
- Mar 2013
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of ciliary neurotrophic factor in achromatopsia (ACHM), sponsored by National Eye Institute. Started Jul 2012; status: completed.
02
Drugs
ciliary neurotrophic factor
03
Conditions
achromatopsia (ACHM)
Beyond the preview
Go deeper on NCT01648452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01648452.